Children's Hospital Medical Center, Cincinnati

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Children's Hospital Medical Center, Cincinnati sits in the top decile of US sponsors by registered trial count (#60 of 15,742 sponsors by registered trial count).

571 total trials 106 currently recruiting 372 completed early-phase tilt top decile by trial count

Children's Hospital Medical Center, Cincinnati: 571 sponsored US clinical trials, 106 recruiting.

Children's Hospital Medical Center, Cincinnati sponsors 571 registered US clinical trials on ClinicalTrials.gov, 106 of them currently recruiting, and 372 completed. 38 of these trials are in Phase 3-4 (later-stage) and 140 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 13 trials.

Top-decile sponsor footprint

Children's Hospital Medical Center, Cincinnati ranks in the top decile of sponsors by registered trial count (#60 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 65/100

372 of 412 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

571 total, page 12 of 12

COMPLETED

Follow-up of Adolescent Bariatric Surgery

NCT00776776

COMPLETED Phase 2

Trial of Growth Hormone Therapy in Pediatric Crohn's Disease

NCT00109473

COMPLETED NA

Role of Carbohydrate Modification in Weight Management Among Obese Children

NCT00215111

TERMINATED Phase 4

Ketorolac Versus Ibuprofen to Treat Painful Episodes of Sickle Cell Disease

NCT00115336

COMPLETED Phase 3

Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders

NCT00221403

COMPLETED Phase 3

Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study

NCT00088452

COMPLETED Phase 1

Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi Anemia

NCT00243399

COMPLETED Phase 3

Coping Skills Training for Adolescents With Fibromyalgia

NCT00086047

COMPLETED NA

Randomized Controlled Trial of Multi-Source Feedback to Pediatric Residents

NCT00302783

COMPLETED

Facilitated Referral for Children Screening Positive for Mental Illness

NCT00448331

COMPLETED Phase 2

Triptorelin for Ovary Protection in Childhood Onset Lupus

NCT00124514

COMPLETED Phase 1

Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD)

NCT00166595

COMPLETED Phase 2

Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM

NCT00457808

TERMINATED Phase 2

Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis

NCT00035958

COMPLETED Phase 1

Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD)

NCT00147394

COMPLETED Phase 1

Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome

NCT00266565

COMPLETED Phase 3

Lithium Versus Divalproex for Treating Pediatric Bipolar Disorder

NCT00221429

COMPLETED Phase 2

Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease

NCT00004488

COMPLETED NA

Randomized Study of Tauroursodeoxycholic Acid in Prophylactic Therapy of Total Parenteral Nutrition Associated Cholestasis in Infants

NCT00004410

COMPLETED NA

Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis

NCT00004441

COMPLETED Phase 2

Calcium Supplements for Bone Health in Juvenile Rheumatoid Arthritis

NCT00000429

← Previous Page 12 of 12

Phase Distribution

PhaseTrial count
Phase 1 86
Phase 2 54
Phase 3 15
Phase 4 23

What is open in the Children's Hospital Medical Center, Cincinnati pipeline

106 recruiting of 571 indexed (19% open); 372 completed (65%).

Phase mix: 38 late (III/IV) vs 140 early (I/II) (early-phase heavy).

Top condition: Autism Spectrum Disorder (13 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Children's Hospital Medical Center, Cincinnati: open-pipeline peers nationwide

Peers matched on 571 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

Children's Hospital Medical Center, Cincinnati sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600800 5%10%15%20%25%30% Total trials Recruiting share Children's Hospital Medical Center, CincinnatiNational Institute of Neurological Disorders and Stroke (NINDS)City of Hope Medical CenterUniversity of Maryland, BaltimoreAmgenArkansas Children's Hospital Research InstituteUniversity of Missouri-ColumbiaMclean HospitalMontefiore Medical Center
Children's Hospital Medical Center, Cincinnati sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Children's Hospital Medical Center, Cincinnati sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 571 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this Children's Hospital Medical Center, Cincinnati page

571 registered trials is a research-attention snapshot, not an endorsement of Children's Hospital Medical Center, Cincinnati or any single study.

  • 106 of Children's Hospital Medical Center, Cincinnati's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Autism Spectrum Disorder is the condition Children's Hospital Medical Center, Cincinnati studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autism Spectrum Disorder trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Children's Hospital Medical Center, Cincinnati pipeline card: 571 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.